Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Average Rating of “Buy” by Brokerages

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) has earned a consensus rating of “Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and four have assigned a strong buy recommendation to the company.

Several brokerages recently weighed in on RBGLY. Sanford C. Bernstein downgraded shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 4th. Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a report on Tuesday, October 1st. Barclays upgraded Reckitt Benckiser Group to a “strong-buy” rating in a report on Friday, October 4th. HSBC raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Finally, Hsbc Global Res raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, December 11th.

Read Our Latest Research Report on RBGLY

Reckitt Benckiser Group Stock Up 1.0 %

RBGLY stock opened at $12.69 on Friday. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. The firm has a 50 day moving average price of $12.18 and a 200-day moving average price of $11.92. Reckitt Benckiser Group has a 52-week low of $10.24 and a 52-week high of $15.03.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.